Cargando…

MicroRNA Expression Profiles and Breast Cancer Chemotherapy

Breast cancer is the most common malignancy diagnosed in women. Traditionally, radical surgical resection was the cornerstone of breast cancer management, with limited exceptions. In recent times, our enhanced appreciation of the biomolecular characteristics of breast cancer has transformed the trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davey, Matthew G., Lowery, Aoife J., Miller, Nicola, Kerin, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509379/ https://www.ncbi.nlm.nih.gov/pubmed/34639152 http://dx.doi.org/10.3390/ijms221910812

Ejemplares similares

The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment
por: Davey, Matthew G., et al.
Publicado: (2021)

MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer
por: Davey, Matthew G., et al.
Publicado: (2022)

Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
por: Davey, Matthew G, et al.
Publicado: (2022)

Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer
por: Davoren, Pamela A, et al.
Publicado: (2008)

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
por: Richard, Vinitha, et al.
Publicado: (2021)

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
por: Davey, Matthew G., et al.
Publicado: (2023)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
por: McGuire, Andrew, et al.
Publicado: (2020)

Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G., et al.
Publicado: (2022)

Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

MicroRNAs as Novel Biomarkers for Breast Cancer
por: Heneghan, H. M., et al.
Publicado: (2010)

Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer
por: Abbas Syed, Raza, et al.
Publicado: (2023)

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer
por: Lowery, Aoife J, et al.
Publicado: (2009)

Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer
por: Chang, Kah Hoong, et al.
Publicado: (2010)

Circulating microRNAs: promising breast cancer Biomarkers
por: Heneghan, Helen M, et al.
Publicado: (2011)

Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence—A Systematic Review
por: Bouz Mkabaah, Luis, et al.
Publicado: (2023)

Dysregulated miR-183 inhibits migration in breast cancer cells
por: Lowery, Aoife J, et al.
Publicado: (2010)

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G, et al.
Publicado: (2022)

Evaluating the Clinical Utility of Routine Sentinel Lymph Node Biopsy and the Value of Adjuvant Chemotherapy in Elderly Patients Diagnosed With Oestrogen Receptor Positive, Clinically Node Negative Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2021)

Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer
por: Davey, Matthew G., et al.
Publicado: (2022)

Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Molecular profiling in contemporary breast cancer management
por: Davey, Matthew G, et al.
Publicado: (2023)

Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: a systematic review
por: Lunardi, Mattia, et al.
Publicado: (2022)

MicroRNA expression profiling of male breast cancer
por: Fassan, Matteo, et al.
Publicado: (2009)

Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Preoperative Breast Magnetic Resonance Imaging as a Predictor of Response to Neoadjuvant Chemotherapy
por: Browne, Robert, et al.
Publicado: (2022)

A radiomic model to classify response to neoadjuvant chemotherapy in breast cancer
por: McAnena, Peter, et al.
Publicado: (2022)

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
por: Kerin, Eoin P., et al.
Publicado: (2022)

Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials
por: Davey, Matthew G., et al.
Publicado: (2022)

Optimal primary wound closure methods after thyroid and parathyroid surgery: network meta-analysis of randomized clinical trials
por: Davey, Matthew G, et al.
Publicado: (2023)

Breast cancer recurrence: factors impacting occurrence and survival
por: Courtney, Donald, et al.
Publicado: (2022)

MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid
por: Khan, Sonja, et al.
Publicado: (2015)

Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer
por: Waters, Peadar S., et al.
Publicado: (2012)

MicroRNA expression profiling in male and female familial breast cancer
por: Pinto, R, et al.
Publicado: (2014)

A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group
por: Kelly, Brian D., et al.
Publicado: (2015)

Evaluating the Fragility of Long-Term Outcomes for Neoadjuvant versus Adjuvant Chemotherapy Prescription in Early Breast Cancer: Pooled Data from 10 Randomised Clinical Trials
por: Davey, Matthew G, et al.
Publicado: (2022)

Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety
por: O’Halloran, Niamh, et al.
Publicado: (2017)

Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling
por: Chen, Junqing, et al.
Publicado: (2018)

MicroRNA expression profiles of serum from patients before and after chemotherapy
por: Diener, Yvonne, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iq23nn8tgt8glvmm0u5eiv4jvn